Back
Bristol-Myers Squibb Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
40
BMY
Bristol-Myers Squibb
Last Price:
$44.11
Seasonality Move:
-0.3%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
Bristol-Myers Squibb Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.18 | Sell |
20-day SMA: | 48.4 | Sell |
50-day SMA: | 54.13 | Sell |
200-day SMA: | 54.03 | Sell |
8-day EMA: | 46.93 | Sell |
20-day EMA: | 48.81 | Sell |
50-day EMA: | 52.12 | Sell |
200-day EMA: | 53.73 | Sell |
Bristol-Myers Squibb Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.09 | Sell |
Relative Strength Index (14 RSI): | 29.25 | Sell |
Chaikin Money Flow: | -19846726 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.1 - 50.84) | Sell |
Bollinger Bands (100): | (51.35 - 60.03) | Sell |
Bristol-Myers Squibb Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Bristol-Myers Squibb Stock
Is Bristol-Myers Squibb Stock a Buy?
-
Bristol-Myers Squibb share price is 44.12 while BMY 8-day simple moving average is 47.18, which is a Sell signal.
-
The stock price of BMY is 44.12 while Bristol-Myers Squibb 20-day SMA is 48.40, which makes it a Sell.
-
Bristol-Myers Squibb 50-day simple moving average is 54.13 while BMY share price is 44.12, making it a Sell technically.
-
BMY stock price is 44.12 and Bristol-Myers Squibb 200-day simple moving average is 54.03, creating a Sell signal.
BMY Technical Analysis vs Fundamental Analysis
Sell
40
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy or a Sell?
-
Bristol-Myers Squibb stock is rated a SellThe current Bristol-Myers Squibb [BMY] share price is $44.12. The Score for BMY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Bristol-Myers Squibb Stock Info
Market Cap:
89.8B
Price in USD:
44.12
Share Volume:
21.7M
Bristol-Myers Squibb 52-Week Range
52-Week High:
63.33
52-Week Low:
39.35
Sell
40
Bristol-Myers Squibb (BMY)
is a Sell
Bristol-Myers Squibb Share Price Forecast
-
What is the Bristol-Myers Squibb stock price today?The Bristol-Myers Squibb stock price is 44.12 USD today.
-
Will BMY stock go up or go down?Bristol-Myers Squibb> share price is forecast to RISE/FALL based on technical indicators
-
Is Bristol-Myers Squibb overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bristol-Myers Squibb is overvalued.
Is Bristol-Myers Squibb Stock a Buy?
-
Bristol-Myers Squibb share price is 44.12 while BMY 8-day exponential moving average is 46.93, which is a Sell signal.
-
The stock price of BMY is 44.12 while Bristol-Myers Squibb 20-day EMA is 48.81, which makes it a Sell.
-
Bristol-Myers Squibb 50-day exponential moving average is 52.12 while BMY share price is 44.12, making it a Sell technically.
-
BMY stock price is 44.12 and Bristol-Myers Squibb 200-day simple moving average is 53.73, creating a Sell signal.
Fundamental Analysis of Bristol-Myers Squibb
Is Bristol-Myers Squibb a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.17 per share, an increase this year of $5.95 per share, and a decrease next year of $0.79 per share.
Technical Analysis of Bristol-Myers Squibb
Should I short Bristol-Myers Squibb stock?
-
BMY Moving Average Covergence Divergence (MACD) indicator is -2.09, suggesting Bristol-Myers Squibb is a Sell
-
Bristol-Myers Squibb Relative Strength Index (RSI) is 29.25, which suggest Bristol-Myers Squibb is oversold
-
The Bollinger Bands (25) for Bristol-Myers Squibb is (47.1 - 50.84), which suggest Bristol-Myers Squibb is a Sell
-
The Bollinger Bands (100) for Bristol-Myers Squibb is (51.35 - 60.03), which suggest Bristol-Myers Squibb is a Sell
* Bristol-Myers Squibb stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.